Monitor for a reverse stock split announcement or further stock price deterioration. The stock continues to trade normally on Nasdaq, but delisting risk is real if the bid price does not recover organically or via corporate action. Watch for any capital raise or business update that could restore investor confidence and lift the stock above $1.00.
Price Chart
Executive Summary
InspireMD received a Nasdaq delisting notice on July 17, 2026 for failing to maintain the minimum $1.00 bid price over 30 consecutive business days. The company has 180 calendar days (until January 13, 2027) to regain compliance, potentially through a reverse stock split. Failure to cure could lead to delisting from the Nasdaq Capital Market, severely impacting liquidity and institutional ownership.
Key Facts
- Nasdaq notified InspireMD on July 17, 2026 that its common stock failed to maintain the minimum $1.00 bid price for 30 consecutive business days (June 3–July 16, 2026)
- The company has a 180-calendar-day compliance period, ending January 13, 2027, to regain compliance under Nasdaq Listing Rule 5810(c)(3)(A)
- To cure, the closing bid price must be at least $1.00 for a minimum of 10 consecutive business days; Nasdaq may require a longer period
- If not cured by January 13, 2027, the company may be eligible for an additional 180-day period if it meets other listing standards and provides notice of intent to cure via a reverse stock split
- The company intends to evaluate options including a reverse stock split, but there is no assurance of regaining compliance
Financial Impact
No financial figures provided in the filing; market cap is $33M with negligible institutional ownership (~$700 from top holder)
Risk Factors
- Failure to regain compliance within 180 days could lead to delisting, severely reducing liquidity and institutional access
- A reverse stock split, if pursued, could be perceived negatively and may not hold the stock above $1.00 long-term
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (NSPR) — Batch item 1 | 0001493152-26-034430 |
| Document: 0001493152-26-034430-index-headers.html | 0001493152-26-034430 |
| Document: 0001493152-26-034430-index.html | 0001493152-26-034430 |
| Document: 0001493152-26-034430.txt | 0001493152-26-034430 |
| 8-K Filing (NSPR) — Batch item 5 | 0001493152-26-034430 |
| Document: 0001493152-26-034430-index-headers.html | 0001493152-26-034430 |
| Document: 0001493152-26-034430-index.html | 0001493152-26-034430 |
| Document: 0001493152-26-034430.txt | 0001493152-26-034430 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 21, 2026 5w ago | 8-K | $0.7500 $0.6895 | ▼ −8.07% | ▼ −7.05% | $0.4500 (−40.00%) |
Sep 21, 2026 5w ago | Press Release | $0.7500 $0.6895 | ▼ −8.07% | ▼ −7.05% | $0.4500 (−40.00%) |
Aug 17, 2026 10w ago | 8-K | $0.8798 $0.8699 | ▲ +1.13% | ▼ −0.07% | $0.4500 (+48.85%) |
Aug 17, 2026 10w ago | Press Release | $0.8798 $0.8699 | ▲ +1.13% | ▼ −0.07% | $0.4500 (+48.85%) |
Aug 10, 2026 11w ago | Press Release | $0.8500 $0.8816 | ▲ +3.72% | ▲ +4.12% | $0.4500 (−47.06%) |
Jul 29, 2026 12w ago | 8-K | $0.6718 $0.7222 | ▲ +7.50% | ▲ +3.88% | $0.4500 (−33.02%) |
Jul 23, 2026 13w ago | 8-K | $0.6835 $0.6718 | ▲ +1.71% | ▲ +2.09% | $0.4500 (+34.16%) |
Jul 2, 2026 16w ago | 8-K | $0.6990 $0.7121 | ▲ +1.87% | ▲ +0.94% | $0.4500 (−35.62%) |
May 21, 2026 22w ago | Insider Cluster | $1.00 $0.9900 | ▼ −1.00% | ▼ −2.66% | $0.4500 (−55.00%) |
May 15, 2026 23w ago | Insider Cluster | $1.05 $0.9500 | ▼ −9.52% | ▼ −11.14% | $0.4500 (−57.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers